Tekstiviesti: HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE IN HEPATITIS C VIRUS INFECTED INJECTION DRUG USERS RECEIVING DIRECTLY OBSERVED THERAPY WITH PEGINTERFERON ALPHA 2A (40DK) (PEGASYS) AND ONCE DAILY RIBAVIRIN